Prevalence of hypertension in IDDM patients in the Northern Grand Canary Island, according to the WHO/ISH and JNC-V/ADA criteria

Diabetes Research and Clinical Practice

Volumn 38, Issue 3, 1997, Pages 191-197

  De Pablos Velasco, Pedro L ^a   Martínez Martín, Francisco J ^a   Aguilar, Joséa ^a  

^a Hospital Nuestra Senora del Pino   (Spain)

Author keywords

Dislipemia; Hypertension; Nephropathy; Prevalence; Type 1 diabetes

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEINURIA; RISK FACTOR; SPAIN;

ADOLESCENT; ADULT; ALBUMINURIA; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIASTOLE; DISEASE PROGRESSION; FEMALE; GUIDELINES; HUMANS; HYPERTENSION; LIPID METABOLISM; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; SEX FACTORS; SPAIN; SYSTOLE; WORLD HEALTH ORGANIZATION;

EID: 0345367906     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00097-1     Document Type: Article

References (25)

1. Ebstein M., Sowers J.R. Diabetes mellitus and hypertension. Hypertension. 19:1992;403-418.
2. Parving H.-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy and endothelial permeability in diabetes mellitus. Diabetes Care. 14:1991;260-269.
3. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. New Engl. J. Med. 311:1984;89-93.
4. Mattock M.B., Morrish N.J., Viberti J.C., Keen H., Fitzgerald A.P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741.
5. Borch-Johnsen K., Andersen P.K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 28:1985;590-596.
6. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch. Intern. Med. 153:1993;154-183.
7. Treatment of hypertension in diabetes. Diabetes Care. 16:1993;1394-1401.
8. National High Blood Pressure Education Program Working Group report of hypertension in diabetes. Hypertension. 23:1994;145-158.
9. Tarnow L., Rossing P., Gall M.-A., Nielsen F.S., Parving H.-H. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care. 17:1994;1247-1251.
10. 1993 guidelines for the management of mild hypertension: Memorandum from a World Health Organisation/ International Society of Hypertension meeting. J. Hypertens. 11:1993;905-918.
11. Teppo A.M. Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin. Chem. 28:1982;1359-1361.
12. Hassemer D.J., Koch D.D., Wiebe D.A. Four commercially available cholesterol meet NCEP guidelines. Clin. Chem. 34:1988;1231-1236.
13. McGowan T.A., Artiss J.D., Strandbergh D.R. et al. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29:1983;538-542.
14. Draeger B., Wahlefeld A.W., Ziegenhorn J. Method for the precipitation of serum HDL cholesterol. Clin. Chem. 28:1983;1574-1578.
15. Parving H.H., Hommel E., Mathiesen E.R. et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and nephropathy in insulin-dependent diabetes mellitus. Br. Med. J. 296:1983;156-160.
16. Julius S., Jamerson K. The HOT study. US versus the world experiences. Am. J. Hypertens. 8:1995;1A.
17. Fuller J.H., Stevens L.K. Epidemiology of hypertension in diabetic patients and implications for treatment. Diabetes Care. 114(Suppl. 4):1991;8-12.
18. S. Savage, N.N. Johnson, R.O. Estacio et al., The ABCD (Appropriate Blood pressure Control in Diabetes) trial: rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. Online J. Cur. Clin. Trials, 24 November 1993, Doc No. 104.
19. Kannel W.B. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Ann. Int. Med. 87:1977;393-397.
20. Wiegmann T.B., Herron K.G., Chonko A.M., McDougall M.L., More V.W. Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recording in type 1 diabetes mellitus. Diabetes. 39:1990;1556-1560.
21. Lewis E., Hunsicker L., Bain R., Rhode R. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. New Engl. J. Med. 329:1993;1456-1462.
22. Viberti G.C., Mogensen C.E., Groop L.C., Pauls J.F. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. J. Am. Med. Assoc. 271:1994;275-279.
23. Ravid M., Lang R., Rachmani R., Lishner M. Long term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch. Int. Med. 156:1996;286-289.
24. Allawi J., Jarret R.J. Microalbuminuria and cardiovascular risk factors in diabetes mellitus. Diabetic Med. 7:1990;115-180.
25. Hypertension et diabète. Diabetes Metab. 22:1996;64-76.